Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels

Clinical trial NCT02375828 · COMPLETED

Trial details

NCT number: NCT02375828
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neonatal Diabetes Secondary to Mutation in the Potassium Channel

Start date: 2015-03-20
Primary completion: 2016-03-04
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.